Loading clinical trials...
Loading clinical trials...
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
Conditions
Interventions
Abivertinib
Standard of Care
Locations
6
United States
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States
Teradan Clinical Trials
Brandon, Florida, United States
Alexandria Cardiology Clinic
Alexandria, Louisiana, United States
Clinical Trials of SWLA
Lake Charles, Louisiana, United States
Quality Clinical Research
Omaha, Nebraska, United States
Memorial Hermann Memorial City Hospital
Houston, Texas, United States
Start Date
October 9, 2020
Primary Completion Date
July 1, 2021
Completion Date
August 23, 2021
Last Updated
January 18, 2023
NCT04565665
NCT04978571
NCT06082518
NCT07221162
NCT06631287
NCT06679140
Lead Sponsor
Sorrento Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions